These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 17376748)

  • 21. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
    Fosslien E
    Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diseases of the human mitochondrial oxidative phosphorylation system].
    Ruiz-Pesini E; López-Gallardo E; Dahmani Y; Herrero MD; Solano A; Díez-Sánchez C; López-Pérez M; Montoya J
    Rev Neurol; 2006 Oct 1-15; 43(7):416-24. PubMed ID: 17006861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease.
    Sharer JD
    IUBMB Life; 2005 Sep; 57(9):607-14. PubMed ID: 16203679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genetics and pathology of oxidative phosphorylation.
    Smeitink J; van den Heuvel L; DiMauro S
    Nat Rev Genet; 2001 May; 2(5):342-52. PubMed ID: 11331900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA-related disorders.
    Mancuso M; Filosto M; Choub A; Tentorio M; Broglio L; Padovani A; Siciliano G
    Biosci Rep; 2007 Jun; 27(1-3):31-7. PubMed ID: 17484046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An introduction: oxidative phosphorylation diseases.
    Shoffner JM
    Semin Neurol; 2001 Sep; 21(3):237-50. PubMed ID: 11641814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial disorders due to nuclear OXPHOS gene defects.
    Ugalde C; Morán M; Blázquez A; Arenas J; Martín MA
    Adv Exp Med Biol; 2009; 652():85-116. PubMed ID: 20225021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular research technologies in mitochondrial diseases: the microarray approach.
    Crimi M; O'Hearn SF; Wallace DC; Comi GP
    IUBMB Life; 2005 Dec; 57(12):811-8. PubMed ID: 16393784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diseases caused by mutations in mitochondrial DNA].
    Wojewoda M; Zabłocki K; Szczepanowska J
    Postepy Biochem; 2011; 57(2):222-9. PubMed ID: 21913424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the mitochondrial encoded subunits of complex I in 20 patients with a complex I deficiency.
    Meulemans A; Lissens W; Van Coster R; De Meirleir L; Smet J; Nassogne MC; Liebaers I; Seneca S
    Eur J Paediatr Neurol; 2004; 8(6):299-306. PubMed ID: 15542384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondria and degenerative disorders.
    Orth M; Schapira AH
    Am J Med Genet; 2001; 106(1):27-36. PubMed ID: 11579422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative phosphorylation disease diagnosis.
    Shoffner JM
    Semin Neurol; 1999; 19(4):341-51. PubMed ID: 10716657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons.
    Janssen GM; Hensbergen PJ; van Bussel FJ; Balog CI; Maassen JA; Deelder AM; Raap AK
    Hum Mol Genet; 2007 Oct; 16(20):2472-81. PubMed ID: 17656376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial DNA medicine.
    DiMauro S
    Biosci Rep; 2007 Jun; 27(1-3):5-9. PubMed ID: 17484047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial DNA mutations in human disease.
    DiMauro S; Schon EA
    Am J Med Genet; 2001; 106(1):18-26. PubMed ID: 11579421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mitochondrial diseases in children including Leigh syndrome--biochemical and molecular background].
    Pronicka E; Piekutowska-Abramczuk D; Pronicki M
    Postepy Biochem; 2008; 54(2):161-8. PubMed ID: 18807927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency.
    Coenen MJ; Antonicka H; Ugalde C; Sasarman F; Rossi R; Heister JG; Newbold RF; Trijbels FJ; van den Heuvel LP; Shoubridge EA; Smeitink JA
    N Engl J Med; 2004 Nov; 351(20):2080-6. PubMed ID: 15537906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory chain complex I deficiency.
    Triepels RH; Van Den Heuvel LP; Trijbels JM; Smeitink JA
    Am J Med Genet; 2001; 106(1):37-45. PubMed ID: 11579423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of nuclear-mitochondrial intergenomic communication.
    Spinazzola A; Zeviani M
    Biosci Rep; 2007 Jun; 27(1-3):39-51. PubMed ID: 17510790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.
    De Paepe B; Smet J; Lammens M; Seneca S; Martin JJ; De Bleecker J; De Meirleir L; Lissens W; Van Coster R
    J Clin Pathol; 2009 Feb; 62(2):172-6. PubMed ID: 19181635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.